Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Undergraduate Student Research Awards (USRA)

University of British Columbia

$6,000.00

Complement system gene expression in cingulate cortex in individuals with depression

EF 2025-26

Résumé
Major depressive disorder (MDD) has a lifetime prevalence of around 11%, and is associated with significant burden, both for the affected individual, but also their family and community. Symptoms of MDD include sadness, loss of ability to feel pleasure and increased risk of suicide. The pathophysiology underlying this disorder remains unknown, however, an emerging literature implicates a role for inflammation. The complement system is a key player in the immune system and is comprised of a series of proteins that interact to induce an inflammatory response. Intriguingly, new research suggests that the complement system is vital for normal brain function. While increased levels of complement proteins have been reported in blood samples from individuals with MDD, it is unknown whether complement is similarly changed in the brain in this disorder. As such, the aim of this project is to compare complement levels in brain tissue between individuals with MDD and controls. Specifically, mRNA expression of complement system genes, including C4 and C7, will be quantified in postmortem samples of cingulate cortex, obtained from individuals with MDD and matched controls without psychiatric disorder, using quantitative polymerase chain reaction (qPCR). Complement gene expression will be compared between MDD and control groups, with secondary analyses examining effects of suicidal symptoms, sex and other relevant factors. Greater understanding of the relationship between complement system function and psychiatric symptoms could in future lead to improved treatments for depression.
Programme
Undergraduate Student Research Awards (USRA)
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
531062
Name
Olarinde Faithful
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Complement system gene expression in cingulate cortex in individuals with depression
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$6,000
Cihrequipment2
$0
Programname2
Undergraduate Student Research Awards (USRA)
Keyworddelim
Brain Function; Brain Tissue; Depression; Depressive Disorder; Disorder; Inflammation; Proteins; Suicide; Symptoms
Abstract
Major depressive disorder (MDD) has a lifetime prevalence of around 11%, and is associated with significant burden, both for the affected individual, but also their family and community. Symptoms of MDD include sadness, loss of ability to feel pleasure and increased risk of suicide. The pathophysiology underlying this disorder remains unknown, however, an emerging literature implicates a role for inflammation. The complement system is a key player in the immune system and is comprised of a series of proteins that interact to induce an inflammatory response. Intriguingly, new research suggests that the complement system is vital for normal brain function. While increased levels of complement proteins have been reported in blood samples from individuals with MDD, it is unknown whether complement is similarly changed in the brain in this disorder. As such, the aim of this project is to compare complement levels in brain tissue between individuals with MDD and controls. Specifically, mRNA expression of complement system genes, including C4 and C7, will be quantified in postmortem samples of cingulate cortex, obtained from individuals with MDD and matched controls without psychiatric disorder, using quantitative polymerase chain reaction (qPCR). Complement gene expression will be compared between MDD and control groups, with secondary analyses examining effects of suicidal symptoms, sex and other relevant factors. Greater understanding of the relationship between complement system function and psychiatric symptoms could in future lead to improved treatments for depression.
Competitiondate
202505
Approvedterm2
0 yr 4 mths
Pinamesdelim
Olarinde, Faithful
Approvedterm
0 an 4 mois
Cihrcontribution2
~ $6,000~ $0~